45.69
Bruker Corp stock is traded at $45.69, with a volume of 1.51M.
It is up +1.58% in the last 24 hours and up +15.18% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$44.98
Open:
$45.09
24h Volume:
1.51M
Relative Volume:
0.71
Market Cap:
$6.96B
Revenue:
$3.46B
Net Income/Loss:
$-9.40M
P/E Ratio:
-190.06
EPS:
-0.2404
Net Cash Flow:
$51.30M
1W Performance:
+6.55%
1M Performance:
+15.18%
6M Performance:
-3.34%
1Y Performance:
+25.73%
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
BRKR
Bruker Corp
|
45.69 | 6.85B | 3.46B | -9.40M | 51.30M | -0.2404 |
|
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-10-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-09-25 | Initiated | Goldman | Sell |
| Nov-20-25 | Initiated | Rothschild & Co Redburn | Buy |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Corporation (BRKR) Stock Analysis: Exploring a 7.58% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corporation 8-K SEC Filing Summary – Company Information, Address, and Securities Details (May 21, 2026) - Minichart
Bruker stockholders elect directors and approve proposals at annual meeting - Investing.com
Bruker (NASDAQ: BRKR) investors back board slate and auditor at 2026 meeting - Stock Titan
Bruker Corp Annual Shareholders Meeting Transcript - GuruFocus
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
A Look at Bruker Corp (BRKR) After 3.9% Gain -- GF Value $62.37 vs Price $44.27 - GuruFocus
Thrivent Financial for Lutherans Acquires 152,603 Shares of Bruker Corporation $BRKR - MarketBeat
Bruker (BRKR) director receives 2,886 RSUs vesting in 2027 - Stock Titan
Bruker (NASDAQ: BRKR) EVP exercises options and sells 2,000 shares under plan - Stock Titan
BRKR Technical Analysis | Trend, Signals & Chart Patterns | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker Corp stock (US1167941087): upbeat guidance and life-science demand support growth story - AD HOC NEWS
[8-K] BRUKER CORP Reports Material Event - Stock Titan
2,000-share proposed sale via option exercise (BRKR) reported - Stock Titan
Orbis group discloses 11.8% stake in Bruker Corp (BRKR) - Stock Titan
Bruker (NASDAQ:BRKR) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
Bruker Corp (BRKR) Stock Price, Trades & News - GuruFocus
Assessing Whether Bruker (BRKR) Looks Undervalued After Recent Share Price Momentum - Yahoo Finance
Bruker Announces Date and Time of First Quarter 2026 Earnings Release and Webcast - Moomoo
Wall Street Zen Upgrades Bruker (NASDAQ:BRKR) to Buy - MarketBeat
Stifel Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - Moomoo
Bruker Corp. Opens with a 10.16% Gain, Outperforming S&P 500's 1.46% Rise - Markets Mojo
Bruker Corporation (NASDAQ:BRKR) Q1 2026 Earnings Call Transcript - Insider Monkey
Bruker Corp. Hits Day High with 11.29% Surge in Stock Price - Markets Mojo
Bruker Price Target Raised to $45.00/Share From $43.00 by TD Cowen - Moomoo
UBS Maintains Bruker Corp(BRKR.US) With Hold Rating, Raises Target Price to $45 - 富途牛牛
Bruker Is Maintained at Hold by TD Cowen - Moomoo
BRKR Financials: Income Statement, Balance Sheet & Cash Flow | Bruker Corp - Stock Titan
Bruker (NASDAQ: BRKR) Q1 2026 revenue reaches $823M amid restructuring - Stock Titan
UBS Adjusts Price Target on Bruker to $45 From $40, Maintains Neutral Rating - Moomoo
A Quick Look at Today's Ratings for Bruker Corp(BRKR.US), With a Forecast Between $44 to $53 - 富途牛牛
UBS Group AG Lowers Stock Holdings in Bruker Corporation $BRKR - MarketBeat
BRKR Stock Up Post Q1 Earnings & Revenue Beat, Margins Down - Yahoo Finance
BRUKER ($BRKR) Releases Q1 2026 Earnings - Moomoo
TD Cowen Initiates Bruker Corp(BRKR.US) With Hold Rating, Announces Target Price $45 - 富途牛牛
How many employees work at Bruker Optics? - Revelio Labs
BRUKER CORPORATION (BRKR) - MSN
Bruker Q1 Adjusted Earnings Fall, Revenue Rises; Maintains Fiscal 2026 Outlook - Moomoo
Bruker Q1 2026 slides: beats estimates despite organic revenue decline - Investing.com
FMR LLC boosts stake in Bruker (NASDAQ: BRKR) to 12.4% - Stock Titan
Bruker Q1 Earnings Call Highlights - Yahoo Finance
Bruker (NASDAQ:BRKR) Shares Gap Up on Strong Earnings - MarketBeat
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises - Investing.com
Earnings call transcript: Bruker beats Q1 2026 forecasts, stock rises By Investing.com - Investing.com Canada
Opportunity Insights for the $1.1 Billion Preclinical Imaging Industry, 2026Bruker Corp., Cubresa, and Siemens Healthineers Lead - Yahoo Finance UK
Full Transcript: Bruker Q1 2026 Earnings CallBruker (NASDAQ:BRKR) - Benzinga
Q1 2026 Bruker Corp Earnings Call Transcript - GuruFocus
Bruker (NASDAQ:BRKR) Beats Q1 Estimates but Maintains Cautious Full-Year Guidance Amid Organic Revenue Decline - ChartMill
Bruker shares rise 4% on first quarter earnings beat - Investing.com
Bruker shares rise 4% on first quarter earnings beat By Investing.com - Investing.com Canada
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):